Brand Key Point Curated by Functional Medicine Experts , Biohackers & Supported By cutting edge Biomarkers
10.3389/fphar.2022.919202 81 LiuT.WeiH.ZhangL.MaC.WeiY.JiangT.et al (2024)
However, once you have access, it is easy to compare and pricing for each treatment option is clear
Among these targets, 71 were associated with A, Tau, A, and Tau (Figure 11A), specifically, PIK3CD, CDC42, PDE4D, HTR4, ADRA1B, ARG1, PTGS1, PRF1, ADRA2A, CD81, CRYAB, BACE1, CDK2, MDM2, ALDH2, CYP19A1, NOS2, CSNK1D, PRKACA, CSNK2A1, PLCG1, CBS, and MIF were significantly associated with A pathology, EPHB2, LCK, JUN, ZAP70, DPP4, HTR2B, MAPK10, HTR1A, VEGFA, HTR1B, CFTR, CHRM2, GBA2, GSTP1, MMP3, HTR3A, CD4, VDR, MAPK3, and CHEK2 were significantly associated with Tau pathology